However, there is a significant body of literature suggesting that expression and activity of anti-inflammatory HDAC2 are reduced in COPD lungs, airways and alveolar macrophages and becomes worse with severity of the disease [6], [7]. Here, HDAC2 is linked to chronic obstructive pulmonary disease.